Health Care·Life Sciences Tools & Services·$9.4B
TEMPUS AI INC Class A operates in the health care sector, focusing on life sciences tools and services. The company leverages artificial intelligence to enhance patient care and improve health outcomes, making it a key player in the evolving health tech landscape.
EPS
Earnings per share is a critical measure of profitability and will indicate how well the company is managing its costs.
Revenue
Revenue growth is essential for assessing the company's market demand and overall business health.
Wall Street expectations, options signals, track record, and call prep available with Pro.
EPS Beat Streak
5Q
EPS Beat Rate
86%
Avg EPS Surprise
+50.98%
Avg Stock Reaction
+1.79%
In Q4-2025, TEMPUS reported an EPS of $-0.04, significantly beating expectations of $-0.27. The stock reacted positively, gaining 1.15% the following day.
Management Promises & Guidance
Analysts expect TEMPUS to report a loss but are looking for signs of improving revenue. The consensus EPS estimate reflects ongoing challenges in profitability.
Bull Case
If TEMPUS can exceed revenue expectations and narrow its losses, it may signal a turnaround, boosting investor confidence.
Bear Case
Continued losses or lower-than-expected revenue could raise concerns about the company's growth strategy and market position.
EPS
$-0.20Earnings per share is a critical measure of profitability and will indicate how well the company is managing its costs.
Revenue
$345MRevenue growth is essential for assessing the company's market demand and overall business health.
The print will turn on these two things.
Q1
Will TEMPUS achieve revenue of at least $345M this quarter?
Reaching this revenue target is crucial for demonstrating demand for TEMPUS's services and could positively influence investor sentiment.
Q2
Can TEMPUS narrow its EPS loss to $-0.20 or better?
A smaller loss than expected would indicate improved cost management and operational efficiency, which is vital for future growth.
Why consensus could be wrong
The Street may underestimate TEMPUS's potential for revenue growth due to recent advancements in AI applications in health care.
Supporting Evidence
Past earnings surprises indicate a strong potential for exceeding expectations.
The company's recent innovations may not be fully reflected in analyst models.
The health care sector's increasing reliance on AI tools could drive unexpected demand.
Key Risk
If revenue comes in below $340M, it could significantly undermine confidence in TEMPUS's growth strategy.
Pre-commit to what would confirm each case.
This quarter, the market is closely watching TEMPUS's ability to improve its financial performance amidst ongoing challenges.
Bull Confirmed If
Revenue growth exceeding $345M with EPS loss of $-0.20 or better.
Bear Confirmed If
Revenue falling below $340M or an EPS loss greater than $-0.20.
Implied Move
±4.2%
The options market is pricing in a moderate move, suggesting uncertainty around the upcoming earnings report.
Likely market behavior by outcome — not investment advice.
Beat & Raise
If TEMPUS beats expectations, history suggests the stock could rise by about 0.85%, confirming a positive outlook.
In-Line / Cautious
If results are in line with expectations, the stock may experience muted movement as investors await further guidance.
Miss
Should the company miss expectations, history indicates a potential drop of around 7.47%, raising concerns about its growth trajectory.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
PARAMOUNT SKYDANCE C Class B
May 4, 2026